Fox News Stock Drops Dramatically After Tucker Carlson Exit – But is it as Bad as it Seems?
Fox News (FOX) shook the news world up Monday morning announcing long-standing host Tucker Carlson’s departure from the network. As a result, FOX shares dropped nearly 5% in yesterday’s trading sessions, resulting in a $962 million loss in market value. The company’s press release claims this was a mutual parting, but it’s generally believed that there is more to [...]
Super Micro Drops 6% on Warnings of Missing Forecast: 3 Reasons We Still Like This Stock
Early Monday morning, Super Micro (SMCI) issued a warning that the company is going to fall short of its fiscal third-quarter revenue forecast. As a result, the company dropped as much as 12% in pre-market trading and now sits 6% lower than it opened at. While Super Micro originally issued a March-quarter revenue guidance with a midpoint of $1.47 [...]
AT&T’s Weak Q1 Leads to 10% Drop: Is This an Overreaction or a Sign of What’s to Come?
Yesterday, AT&T (T) posted 1st quarter earnings that left much to be desired. While subscriber growth was up, revenue was down - and the market reacted by sending shares down more than 10% in Thursday’s trading session. A key indicator of the telecommunication company’s well-being is postpaid phone plans - a figure representing the number of individuals & businesses [...]
Tesla’s Profitability Woes From Q1 Will Worsen on the Road Ahead – is it Time to Get Out?
It’s been a tough morning for Elon Musk, as not only did SpaceX Starship fail mid-flight - Tesla’s (TSLA) 1st quarter earnings came in overnight and the response has been anything but positive. The company is in the pits of a profitability battle that resulted in a drop to 11.4% in operating margin. This came after price cuts on [...]
The Inside Scoop on Morgan Stanley’s Q1 Performance and Its Implications for Traders
Morgan Stanley (MS) joined other investment banking companies in reporting a lackluster first quarter - one that saw a decline in revenue and profit figures. The company fell victim to a steep drop-off in investment banking revenue, as deals dried up amidst a challenging economic environment. Revenue for the quarter fell 2% from this time last year to just [...]
Amneal Pharma Issues Guidance Over Market Forecasts, But We See 3 Things Holding the Stock Back
Yesterday, Amneal Pharmaceuticals (AMRX) issued guidance for the first quarter of 2023 that came in over the consensus estimates. This sent shares trading as much as 14% higher in premarket trading. The stock opened Monday’s trading session at $1.34/share and closed at $1.63 for a nice single-day gain. The pharmaceutical company says that revenue is going to soar as [...]